Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient

We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paro...

Full description

Saved in:
Bibliographic Details
Main Authors: Anup Bastola, Mitesh Shrestha, Bimal Sharma Chalise, Abhdesh Kumar Mishra, Lina Devkota
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2019/3634568
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564402778275840
author Anup Bastola
Mitesh Shrestha
Bimal Sharma Chalise
Abhdesh Kumar Mishra
Lina Devkota
author_facet Anup Bastola
Mitesh Shrestha
Bimal Sharma Chalise
Abhdesh Kumar Mishra
Lina Devkota
author_sort Anup Bastola
collection DOAJ
description We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paromomycin 15 mg/kg IM for 10 days against the second episode, the patient suffered from a third relapse and was eventually treated with miltefosine 50 mg BID directly observed treatment for 28 days. Prior to treatment, the patient had a history of intermittent fever and vague abdominal pain for one week and epistaxis for 4 days. He had massive splenomegaly, tested positive for the rK39 test, and showed LD bodies in bone marrow aspirate. The patient tested negative for malaria and HIV. Upon treatment completion with miltefosine, the patient had clinically improved and showed no LD bodies in bone marrow.
format Article
id doaj-art-570d0b1d07f44595b1d5ede21a30c675
institution Kabale University
issn 2090-6625
2090-6633
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-570d0b1d07f44595b1d5ede21a30c6752025-02-03T01:11:04ZengWileyCase Reports in Infectious Diseases2090-66252090-66332019-01-01201910.1155/2019/36345683634568Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse PatientAnup Bastola0Mitesh Shrestha1Bimal Sharma Chalise2Abhdesh Kumar Mishra3Lina Devkota4Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, NepalResearch Institute for Bioscience and Biotechnology, Kathmandu, NepalSukraraj Tropical & Infectious Disease Hospital, Kathmandu, NepalSukraraj Tropical & Infectious Disease Hospital, Kathmandu, NepalSukraraj Tropical & Infectious Disease Hospital, Kathmandu, NepalWe report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paromomycin 15 mg/kg IM for 10 days against the second episode, the patient suffered from a third relapse and was eventually treated with miltefosine 50 mg BID directly observed treatment for 28 days. Prior to treatment, the patient had a history of intermittent fever and vague abdominal pain for one week and epistaxis for 4 days. He had massive splenomegaly, tested positive for the rK39 test, and showed LD bodies in bone marrow aspirate. The patient tested negative for malaria and HIV. Upon treatment completion with miltefosine, the patient had clinically improved and showed no LD bodies in bone marrow.http://dx.doi.org/10.1155/2019/3634568
spellingShingle Anup Bastola
Mitesh Shrestha
Bimal Sharma Chalise
Abhdesh Kumar Mishra
Lina Devkota
Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
Case Reports in Infectious Diseases
title Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
title_full Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
title_fullStr Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
title_full_unstemmed Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
title_short Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
title_sort miltefosine rescue treatment for visceral leishmaniasis relapse patient
url http://dx.doi.org/10.1155/2019/3634568
work_keys_str_mv AT anupbastola miltefosinerescuetreatmentforvisceralleishmaniasisrelapsepatient
AT miteshshrestha miltefosinerescuetreatmentforvisceralleishmaniasisrelapsepatient
AT bimalsharmachalise miltefosinerescuetreatmentforvisceralleishmaniasisrelapsepatient
AT abhdeshkumarmishra miltefosinerescuetreatmentforvisceralleishmaniasisrelapsepatient
AT linadevkota miltefosinerescuetreatmentforvisceralleishmaniasisrelapsepatient